Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6241691 | Respiratory Medicine | 2014 | 5 Pages |
Abstract
In summary, this study demonstrates that iodinated activated charcoal surprisingly and significantly improved lung function of patients with moderate COPD. The underlying mechanism of action is unclear, but is likely to be different from the drugs used today. The immediate conclusion is that further studies are now justified in order to determine clinical efficacy of IAC in COPD and explore possible mechanisms of action.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Staffan Skogvall, Jonas S. Erjefält, Anders I. Olin, Jaro Ankerst, Leif Bjermer,